Compounds > gefitinib
Page last updated: 2024-09-03

gefitinib and novobiocin

gefitinib has been researched along with novobiocin in 5 studies

Compound Research Comparison

Studies
(gefitinib)		Trials
(gefitinib)		Recent Studies (post-2010)
(gefitinib)		Studies
(novobiocin)		Trials
(novobiocin)		Recent Studies (post-2010) (novobiocin)
5,2315662,9192,27115290

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)novobiocin (IC50)
DNA gyrase subunit BMycolicibacterium smegmatis MC2 1550.046
DNA gyrase subunit BStaphylococcus aureus0.0474
DNA gyrase subunit BStreptococcus pneumoniae TIGR40.037
DNA gyrase subunit AEscherichia coli K-120.1441
DNA gyrase subunit BEscherichia coli K-120.1537
DNA topoisomerase 4 subunit BStaphylococcus aureus7.9
DNA gyrase subunit BMycolicibacterium smegmatis0.161
DNA gyrase subunit AStaphylococcus aureus0.0383
DNA gyrase subunit BMycobacterium tuberculosis H37Rv0.0446
DNA gyrase subunit AMycobacterium tuberculosis H37Rv0.1315
DNA topoisomerase Streptococcus pneumoniae2.03

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Müller, H; Pick, A; Wiese, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M1
Ekins, S; Williams, AJ; Xu, JJ1
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF1

Reviews

1 review(s) available for gefitinib and novobiocin

ArticleYear
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells

2022

Other Studies

4 other study(ies) available for gefitinib and novobiocin

ArticleYear
Novel lead for potent inhibitors of breast cancer resistance protein (BCRP).
    Bioorganic & medicinal chemistry letters, 2010, Jan-01, Volume: 20, Issue:1

    Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Benzimidazoles; Cell Line, Tumor; Chlorophyll; Humans; Molecular Conformation; Neoplasm Proteins; Phenylurea Compounds; Small Molecule Libraries

2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:11

    Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010